BioSpace News Archive

Nes-Ziona, Israel, Feb. 24, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today announced that it has entered into definitive agreements with certain institutional investors for the purchase in a registered direct offering of an aggregate of 1,000,000 ordinary shares of the Company at a purchase price of $8.00 per share. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. The gross proceeds to the

Frontage Holdings Corporation, a contract research organization providing integrated, science-driven, product development services, is pleased to announce the expansion of its bioanalytical laboratories in Exton, PA, through its wholly-owned subsidiary, Frontage Laboratories, Inc.

LEXINGTON, Mass., Feb. 24, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced financial results for the fourth quarter and full year ended December 31, 2019. Fourth Quarter and Recent Business and Financial Performance Highlights Achieved fourth quarter total revenue of $3.1 million and product revenue of $1.6 million, representing increases of 71% and 18% respectively, compared to the prior year period

EMERYVILLE, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, will report fourth quarter and full year 2019 financial results on Wednesday, March 11, 2020, after the U.S. financial markets close. Dynavax will host a conference call and live audio webcast on Wednesday, March 11, 2019 at 4:30 p.m. (ET)/1:30 p.m. (PT). The live audio webcast may be accessed through

Alkermes plc announced that its Chief Executive Officer, Richard Pops, will present at the Cowen and Company 40th Annual Health Care Conference on Monday, March 2, 2020 at 3:30 p.m. ET from Boston.

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today reported financial results for the fourth quarter and full year ended December 31, 2019.

LogiTag Medical Solutions announced the launch of its patent-protected Snap & Go image recognition technology that captures, records and bills medical implants and consumables used during surgery.

Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, announced that management will present at four upcoming investor conferences

Aetna, a CVS Health company, is now offering fully insured and self-insured health care network options to its Health Maintenance Organization and Exclusive Product Organization product portfolios through Aetna Whole HealthSM – Atlanta.

LA JOLLA, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL) , a clinical stage biopharmaceutical company developing therapeutics that modulate the endocannabinoid system, announced today that Gregory D. Gorgas, President and Chief Executive Officer of Artelo Biosciences, will be presenting at Biocom’s 10 th Annual Global Life Sciences Partnering Conference on February 26, 2020 at 3:45pm Pacific Time at the Lodge at Torrey Pines, La Jolla, CA. T